[4] Other symptoms may include shortness of breath, feeling faint, a smooth red tongue, pale skin, chest pain, nausea and vomiting, loss of appetite, heartburn, numbness in the hands and feet, difficulty walking, memory loss, muscle weakness, poor reflexes, blurred vision, clumsiness, depression, and confusion
Signature and Credential Requirements Electronic or handwritten signatures accepted if compliant with payer guidelines
Active Ingredient : SLU-PP-332 (Quantity as per selected variant) Inactive Ingredients : Excipients Bottle of 100 tablets Test Certificate: Provided for quality confirmation SLU-PP-332 5 out of 5 based on 1 customer rating EUR 119.87 EUR 119.87 EUR 119.87 sample SLU32 is a research-grade ERR agonist available in tablet form at 250 mcg, 500 mcg, and 1 mg strength options
The focus groups also explored whether knowing about medication to treat the early stages of Alzheimer's influenced the timing of diagnosis
Gastrointestinal applications warrant symptom diaries, quality of life measures, and endoscopic assessment when indicated
